INS and metabolic dysfunction-associated steatotic liver disease: IR, assessable through homeostatic model assessment for insulin resistance [27, 28], insulin sensitivity index [29], and quantitative insulin sensitivity check index [28], has been identified to be a risk factor for NAFLD in PCOS.